Nanotechnology-based drug delivery systems.
Suri SS, Fenniri H, Singh B. · 2007
Read Nanotechnology-based drug delivery systems. by Suri SS, Fenniri H, Singh B. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2222591.txt.
Description
Suri, Fenniri and Singh reviewed nanotechnology-based drug delivery systems in 2007. Nanoparticles, particles under 100 nanometres in at least one dimension, can carry drugs inside their core or on their surface. Cells take them up more efficiently than larger molecules. The review covers recent systems for drug and gene delivery, and what governs targeting, release and stability inside the body.
Several cancer drugs, including paclitaxel, doxorubicin and 5-fluorouracil, have been formulated successfully in nanomaterials. Quantum dots, chitosan and biodegradable PLGA particles have delivered RNA interference in lab studies. Doxorubicin bound to nanomaterials crossed the intact blood-brain barrier and reached therapeutic levels in brain, a major hurdle in brain cancer. Peptide nanotubes targeting vessel growth receptors offer another route to control disease progression.
Catalog record
| CREATOR | Suri SS, Fenniri H, Singh B. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |